Todd Goblish Email

VP Research/Development . Respicardia

Minnetonka, MN

Location

LinkedIn

Current Roles

Employees:
107
Revenue:
$26.9M
About
Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia® is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. The first product, the remed® System, is an implantable stimulation device that is designed to restore a more normal breathing pattern during sleep for patients with central sleep apnea. Respicardia® is committed to improving cardiovascular healthone breath at a time.
Respicardia Address
12400 Whitewater Dr
Minnetonka, MN
United States
Respicardia Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.